New

Hypoglycemic Drugs Market

2021

Hypoglycemic Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Insulin, DPP-4, GLP-1, SGLT-2, Other); Application (Type 1 Diabetes, Type 2 Diabetes) and Geography

| Report Code: TIPRE00024470 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Hypoglycemic Drugs Market 2028 Type, Application and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Diabetes mellitus is a metabolic disorder caused when the body cannot produce the required quantity of insulin. Diabetes is characterized into two types; insulin-dependent diabetes mellitus (type 1) and non-insulin dependent diabetes mellitus (type 2). The drugs, which are used for the treatment of type 2 diabetes mellitus are known as hypoglycemic drugs and are utilized for patients who have not responded to diet, weight reduction, and exercise. Various symptoms of diabetes disorder include frequent urination, increased thirst, hunger, and delayed wound healing.

MARKET SCOPE

The "Global Hypoglycemic Drugs Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the hypoglycemic drugs market with detailed market segmentation by type, application, and geography. The report provides key statistics on the market status of the leading hypoglycemic drugs market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on type, the global hypoglycemic drugs market is segmented into insulin, DPP-4, GLP-1, SGLT-2, and other.
  •  On the basis of application, the market is bifurcated into type 1 diabetes, and type 2 diabetes.

MARKET DYNAMICS
Drivers:

  •  Rising incidences of diabetes leading to increased demand for diabetic care and a growing aging population are the factors driving the hypoglycemic drugs market globally.
  •  The growing prevalence of sedentary lifestyle-induced disorders such as obesity and increased consumption of unhealthy diets fuel the market growth.
  •  Growing investment in research and development activities by major pharmaceutical companies and government organizations to develop new products boosts the market growth.
  •  Technological advancement, medical reimbursements, and the presence of a strong pipeline for anti-diabetics drugs also favour the growth of the market.

Restraints:

  •  The enormous unmet medical need for anti-diabetics that can treat multiple chronic disorders coexisting with diabetes such as cardiovascular diseases, hypertension, etc.
  •  Reduction in drug efficacy over a period can lead to other health complications.
  •  High cost of drugs.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The hypoglycemic drugs market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the hypoglycemic drugs market in these regions.

IMPACT OF COVID-19 ON HYPOGLYCEMIC DRUGS MARKET

COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The shutdown of various plants and factories has affected the global supply chains and impacted the overall global market. The pharmaceutical industry is more focused towards the development of the COVID-19 vaccine; thus, research and development efforts for hypoglycemic drugs substantially decline. Though the demand for hypoglycemic drugs is not affected; and it is still as high as before the COVID-19 crisis. Therefore, the market will boost at a significant rate in the forecast period.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the hypoglycemic drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from hypoglycemic drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for hypoglycemic drugs in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the hypoglycemic drugs market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  Sanofi
  •  Merck and Co.
  •  Novo Nordisk
  •  Takeda Pharmaceuticals
  •  Eli Lilly
  •  Pfizer
  •  Boehringer Ingelheim
  •  Novartis
  •  Johnson and Johnson
  •  AstraZeneca
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Hypoglycemic Drugs Market - By Type
1.3.2 Hypoglycemic Drugs Market - By Application
1.3.3 Hypoglycemic Drugs Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. HYPOGLYCEMIC DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. HYPOGLYCEMIC DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. HYPOGLYCEMIC DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. HYPOGLYCEMIC DRUGS - GLOBAL MARKET OVERVIEW
6.2. HYPOGLYCEMIC DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING

7. HYPOGLYCEMIC DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. INSULIN
7.3.1. Overview
7.3.2. Insulin Market Forecast and Analysis
7.4. DPP-4
7.4.1. Overview
7.4.2. DPP-4 Market Forecast and Analysis
7.5. GLP-1
7.5.1. Overview
7.5.2. GLP-1 Market Forecast and Analysis
7.6. SGLT-2
7.6.1. Overview
7.6.2. SGLT-2 Market Forecast and Analysis
7.7. OTHER
7.7.1. Overview
7.7.2. Other Market Forecast and Analysis
8. HYPOGLYCEMIC DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. TYPE 1 DIABETES
8.3.1. Overview
8.3.2. Type 1 Diabetes Market Forecast and Analysis
8.4. TYPE 2 DIABETES
8.4.1. Overview
8.4.2. Type 2 Diabetes Market Forecast and Analysis

9. HYPOGLYCEMIC DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Hypoglycemic Drugs Market Overview
9.1.2 North America Hypoglycemic Drugs Market Forecasts and Analysis
9.1.3 North America Hypoglycemic Drugs Market Forecasts and Analysis - By Type
9.1.4 North America Hypoglycemic Drugs Market Forecasts and Analysis - By Application
9.1.5 North America Hypoglycemic Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 Canada Hypoglycemic Drugs Market
9.1.5.1.1 Canada Hypoglycemic Drugs Market by Type
9.1.5.1.2 Canada Hypoglycemic Drugs Market by Application
9.1.5.2 Mexico Hypoglycemic Drugs Market
9.1.5.2.1 Mexico Hypoglycemic Drugs Market by Type
9.1.5.2.2 Mexico Hypoglycemic Drugs Market by Application
9.1.5.3 US Hypoglycemic Drugs Market
9.1.5.3.1 US Hypoglycemic Drugs Market by Type
9.1.5.3.2 US Hypoglycemic Drugs Market by Application
9.2. EUROPE
9.2.1 Europe Hypoglycemic Drugs Market Overview
9.2.2 Europe Hypoglycemic Drugs Market Forecasts and Analysis
9.2.3 Europe Hypoglycemic Drugs Market Forecasts and Analysis - By Type
9.2.4 Europe Hypoglycemic Drugs Market Forecasts and Analysis - By Application
9.2.5 Europe Hypoglycemic Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Hypoglycemic Drugs Market
9.2.5.1.1 Germany Hypoglycemic Drugs Market by Type
9.2.5.1.2 Germany Hypoglycemic Drugs Market by Application
9.2.5.2 France Hypoglycemic Drugs Market
9.2.5.2.1 France Hypoglycemic Drugs Market by Type
9.2.5.2.2 France Hypoglycemic Drugs Market by Application
9.2.5.3 Italy Hypoglycemic Drugs Market
9.2.5.3.1 Italy Hypoglycemic Drugs Market by Type
9.2.5.3.2 Italy Hypoglycemic Drugs Market by Application
9.2.5.4 Spain Hypoglycemic Drugs Market
9.2.5.4.1 Spain Hypoglycemic Drugs Market by Type
9.2.5.4.2 Spain Hypoglycemic Drugs Market by Application
9.2.5.5 United Kingdom Hypoglycemic Drugs Market
9.2.5.5.1 United Kingdom Hypoglycemic Drugs Market by Type
9.2.5.5.2 United Kingdom Hypoglycemic Drugs Market by Application
9.2.5.6 Rest of Europe Hypoglycemic Drugs Market
9.2.5.6.1 Rest of Europe Hypoglycemic Drugs Market by Type
9.2.5.6.2 Rest of Europe Hypoglycemic Drugs Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Hypoglycemic Drugs Market Overview
9.3.2 Asia-Pacific Hypoglycemic Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Hypoglycemic Drugs Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Hypoglycemic Drugs Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Hypoglycemic Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Hypoglycemic Drugs Market
9.3.5.1.1 Australia Hypoglycemic Drugs Market by Type
9.3.5.1.2 Australia Hypoglycemic Drugs Market by Application
9.3.5.2 China Hypoglycemic Drugs Market
9.3.5.2.1 China Hypoglycemic Drugs Market by Type
9.3.5.2.2 China Hypoglycemic Drugs Market by Application
9.3.5.3 India Hypoglycemic Drugs Market
9.3.5.3.1 India Hypoglycemic Drugs Market by Type
9.3.5.3.2 India Hypoglycemic Drugs Market by Application
9.3.5.4 Japan Hypoglycemic Drugs Market
9.3.5.4.1 Japan Hypoglycemic Drugs Market by Type
9.3.5.4.2 Japan Hypoglycemic Drugs Market by Application
9.3.5.5 South Korea Hypoglycemic Drugs Market
9.3.5.5.1 South Korea Hypoglycemic Drugs Market by Type
9.3.5.5.2 South Korea Hypoglycemic Drugs Market by Application
9.3.5.6 Rest of Asia-Pacific Hypoglycemic Drugs Market
9.3.5.6.1 Rest of Asia-Pacific Hypoglycemic Drugs Market by Type
9.3.5.6.2 Rest of Asia-Pacific Hypoglycemic Drugs Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Hypoglycemic Drugs Market Overview
9.4.2 Middle East and Africa Hypoglycemic Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Hypoglycemic Drugs Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Hypoglycemic Drugs Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Hypoglycemic Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Hypoglycemic Drugs Market
9.4.5.1.1 South Africa Hypoglycemic Drugs Market by Type
9.4.5.1.2 South Africa Hypoglycemic Drugs Market by Application
9.4.5.2 Saudi Arabia Hypoglycemic Drugs Market
9.4.5.2.1 Saudi Arabia Hypoglycemic Drugs Market by Type
9.4.5.2.2 Saudi Arabia Hypoglycemic Drugs Market by Application
9.4.5.3 U.A.E Hypoglycemic Drugs Market
9.4.5.3.1 U.A.E Hypoglycemic Drugs Market by Type
9.4.5.3.2 U.A.E Hypoglycemic Drugs Market by Application
9.4.5.4 Rest of Middle East and Africa Hypoglycemic Drugs Market
9.4.5.4.1 Rest of Middle East and Africa Hypoglycemic Drugs Market by Type
9.4.5.4.2 Rest of Middle East and Africa Hypoglycemic Drugs Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Hypoglycemic Drugs Market Overview
9.5.2 South and Central America Hypoglycemic Drugs Market Forecasts and Analysis
9.5.3 South and Central America Hypoglycemic Drugs Market Forecasts and Analysis - By Type
9.5.4 South and Central America Hypoglycemic Drugs Market Forecasts and Analysis - By Application
9.5.5 South and Central America Hypoglycemic Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Hypoglycemic Drugs Market
9.5.5.1.1 Brazil Hypoglycemic Drugs Market by Type
9.5.5.1.2 Brazil Hypoglycemic Drugs Market by Application
9.5.5.2 Argentina Hypoglycemic Drugs Market
9.5.5.2.1 Argentina Hypoglycemic Drugs Market by Type
9.5.5.2.2 Argentina Hypoglycemic Drugs Market by Application
9.5.5.3 Rest of South and Central America Hypoglycemic Drugs Market
9.5.5.3.1 Rest of South and Central America Hypoglycemic Drugs Market by Type
9.5.5.3.2 Rest of South and Central America Hypoglycemic Drugs Market by Application

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. HYPOGLYCEMIC DRUGS MARKET, KEY COMPANY PROFILES
11.1. SANOFI
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. MERCK AND CO.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. NOVO NORDISK
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. TAKEDA PHARMACEUTICALS
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. ELI LILLY
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. PFIZER
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. BOEHRINGER INGELHEIM
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. NOVARTIS
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. JOHNSON AND JOHNSON
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. ASTRAZENECA
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Sanofi
2. Merck and Co.
3. Novo Nordisk
4. Takeda Pharmaceuticals
5. Eli Lilly
6. Pfizer
7. Boehringer Ingelheim
8. Novartis
9. Johnson and Johnson
10. AstraZeneca
TIPRE00024470
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.